Targeting and inhibiting MerTK and other members of the TAMR family have been considered interesting anti-cancer strategies for reducing tumour development and promoting survival via the alleged MerTK-mediated signalling pathways, including the development of several pan-TAMR small molecule inhibitors and monoclonal antibodies [22,23,24,25,26,27]. Here, MERTK is linked to neoplasm.